Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

¥23.58As of Sun 8 Nov 2026, 12:00 UTC
SSE:600196Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 1.08%
Div yield 1.65%
ROE 7.00%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.43
PE TTM 17.73
TSR TTM (17.83%)
Mkt cap ¥57.86B
ROIC 2.88%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥24
3.41%
(10.59%)
Hold 11|10|6|5|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.25
0.25
0.25
0.27
22.76%
10.53%
4.58%
2.49%
Revenue¥B
3.493
3.508
3.537
3.503
2.09%
2.75%
0.97%
(2.50%)
Peers (US$8.673B)
Cap (US$)
PE
8.695B
32.35x
Capital
TTM
5Y
10Y
Leveragex
4.709
(0.107)
(0.093)
EBIT/Intx
0.741
4.780
3.973
Own earn%
0.48
10.98
11.01
Sh yield%
36.40
46.35
43.25
Owners
Insiders/Inst%
7.96
77.36
Short interest%
1.11
SBC / revenue%
1.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
22–30
$1 testx
0.1
Incr. ROIC%
45